Y-mAbs Therapeutics (YMAB) said Tuesday it signed a lease deal with Princeton 202 Associates to occupy about 10,817 square feet in Princeton, New Jersey.
The company plans to use the facility as its corporate headquarters following occupancy, which is expected in the first half of 2025, according to a filing with the US Securities and Exchange Commission.
The lease will expire 10 years and nine months following possession. The base rent payment due over the lease's initial term is estimated at $3.9 million, Y-mAbs said. The company has two five-year extension options, according to the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments